Brought to you by:
Artivion granted FDA humanitarian device exemption for the AMDS hybrid prosthesis
Artivion recently announced that the Food and Drug Administration (FDA) has granted a humanitarian device exemption (HDE) for use of the AMDS hybrid prosthesis (formerly known as the Ascyrus Medical dissection stent) in acute DeBakey type I dissections in the…
New Florida vascular chief sets vision aimed at improving outcomes through multidisciplinary collaboration and innovation
This advertorial is sponsored by Tampa General Hospital. Early on, Jean Bismuth, MD, acquired a passion for vascular surgery from a world-class source. Back in his Danish homeland, he was drawn into the specialty as an intern by pioneering vascular…
Study finds no correlation between TEVAR timing and uncomplicated type B aortic dissection outcomes
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective of the timing of treatment after dissection. This is according to a study recently published in…
Viz.ai announces positive new data from large aortic dissection AI real-world study
Viz.ai recently announced new data from a large aortic dissection artificial intelligence (AI) real-world study that supports the use of its AI technology for the detection of suspected aortic dissection. Data from the new study, which were presented this week at VEITHsymposium 2022…
NESVS Robert R. Linton Lecture features complex aortic masterclass from Europe
World-leading aortic surgeon Stéphan Haulon, MD, from the Aortic Centre at Hôpital Marie Lannelongue in Paris, France, took attendees of the 2022 New England Society for Vascular Surgery (NESVS) annual meeting on a whirlwind, 15-year journey through the evolution of…
Mortality drops for acute type A aortic dissection, still high for patients not receiving surgery
The chance of a patient surviving after an acute type A aortic dissection has improved significantly, but mortality remains high if not recognized early and repaired surgically. This is according to new research from a team at Michigan Medicine at the University…
Enrollment begins in PERSEVERE clinical trial of hybrid prothesis for aortic dissection
Artivion announced today that it has initiated enrollment in the PERSEVERE clinical trial to determine if patients with an acute DeBakey Type I aortic dissection can be treated safely and effectively using the AMDS hybrid prosthesis. The trial is designed to…
The top 10 most popular Vascular Specialist stories in May 2022
News on the Society for Vascular Surgery (SVS) ballots set to determine the next vice president and secretary, a hard-hitting column about vascular surgery’s role in treating vascular injury, and a look inside the most recent issue of Seminars in…
Collaborators not cases: Engaging patients with aortic dissections as partners in patient-centered outcomes research
To date, research in aortic dissection has focused on management and outcomes focused on technical results, and survival. Little is known about what is important to patients living with or at risk for aortic dissection. The Aortic Dissection Collaborative was…
Research reveals improved outcomes, decreased mortality in management of aortic dissections with multidisciplinary care plans
The Minneapolis Heart Institute Foundation (MHIF) has announced the publication of research showing improved patient outcomes and significantly decreased 30-day mortality in aortic dissection patients managed through a unique comprehensive care strategy designed by a team with multidisciplinary expertise. The manuscript, “Impact of…